Please check out my blog: bkoffman.blogspot.com to view my ASCO 2013 interview of Dr. Wierda explaining the role of the new and old prognostic factors in managing CLL. I added my usual commentary and some references.
ASCO 2013: Dr. Wierda on Prognostic Markers - CLL Support
ASCO 2013: Dr. Wierda on Prognostic Markers
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
1 Reply
•
Long may it continue.Not what you're looking for?
You may also like...
the bad prognostic markers
I know there are multiple posts like this but I just need some help and guidance. My dad just got...
Dr. Wierda on the paradigm shift in CLL.
Dr. Wierda is my doctor and in the short time I met with him in 2017, I didn’t get the impression...
Dr. Wierda on the Importance of Clinical Trials
I’m home from the European Hematology Association Congress in Copenhagen.
I received very positive...
Excellent Overview From Dr. Wierda
“And I think the main message to be optimistic for patients about is, most of us in the academic...
Prognostic markers and the future. Genetic testing.
We have only just scratched the surface with our tests for 13q, 11q 12 tris and 17p.
The real...
Related Posts
Exciting times in CLL: an ASCO 2013 interview with Dr Susan O’Brien- ASCO 2016: Dr. Susan O’Brien where she discusses frontline data on Acalabrutinib in CLL
- ASCO 2014: Dr. Susan O'Brien Reviews the 3 years follow-up Data on Ibrutinib in CLL
- End of suspense! Here is Dr. Koffman's ASCO 2020 "Top Pick" #1!
- ASH 2013: INTERVIEW WITH DR. FURMAN RE: IDELALISIB
